Patents by Inventor Andrew Simon Craig

Andrew Simon Craig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)--(4-(4-fluoro-2-methylphenyl)-6-((7,9a)-7-(hydroxymethyl)hexahydropyrazino[2,1-][1,4]oxazin-8(1)-yl)pyridin-3-yl)-,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same
    Patent number: 8796269
    Abstract: The invention relates to the compound of formula (I) in a crystalline anhydrate form, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: August 5, 2014
    Assignee: Nerre Therapeutics Limited
    Inventors: Andrew Simon Craig, Salima Zarah Ismail, Ronnie Maxwell Lawrence
  • Anhydrate Forms Of A Pyridine Derivative
    Publication number: 20120157450
    Abstract: The invention relates to the compound of formula (I) in a crystalline anhydrate form, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
    Type: Application
    Filed: August 25, 2010
    Publication date: June 21, 2012
    Inventors: Andrew Simon Craig, Salima Zarah Ismail, Ronnie Maxwell Lawrence
  • Quinazoline Salt Compounds
    Publication number: 20110245496
    Abstract: Salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: June 9, 2008
    Publication date: October 6, 2011
    Inventors: Andrew Simon Craig, David Malcolm Crowe, Tim Chien Ting Ho, Michael S. McClure
  • 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
    Patent number: 7291740
    Abstract: Disclosed are 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salts, or solvates thereof; processes for preparing such compounds, compositions comprising such compounds and the use of such compounds in medicine.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: November 6, 2007
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael Millan, Deirdre O'Keeffe
  • Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione
    Patent number: 7074811
    Abstract: A substantially non-hydrated and non-hygroscopic or slightly hygroscopic hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; a pharmaceutical composition containing such a compound, a process of preparing such a compound and the use of such a compound in medicine.
    Type: Grant
    Filed: March 14, 2001
    Date of Patent: July 11, 2006
    Assignee: SmithKline Beecham p.l.c.
    Inventor: Andrew Simon Craig
  • Novel compound
    Publication number: 20040247667
    Abstract: Invented are pharmaceutical compositions containing paroxetine methanesulfonate.
    Type: Application
    Filed: April 21, 2004
    Publication date: December 9, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Ahmad Khalaf Al-Deeb Al-Ghazawi, Andrew Simon Craig, David Philip Elder, Victor Witold Jacewicz, David Alan Jones, Deirdre O'Keeffe, Padma Meneaud, Michael Urquhart, Neal Ward
  • Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione
    Publication number: 20040214866
    Abstract: A compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione sodium salt, or a pharmaceutically acceptable solvate thereof, characterised in that the sodium salt is non-hygroscopic or slightly hygroscapic; a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: May 18, 2004
    Publication date: October 28, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Andrew Simon Craig, Michael Millan
  • Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione
    Publication number: 20040152901
    Abstract: A substantially non-hydrated and non-hygroscopic or slightly hygroscopic hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; a pharmaceutical composition containing such a compound, a process of preparing such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: September 13, 2002
    Publication date: August 5, 2004
    Inventor: Andrew Simon Craig
  • Tartrate salt of thiazolidinedione derivative
    Publication number: 20040102485
    Abstract: A novel pharmaceutical compound 5-[4-2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Meso-Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 21, 2003
    Publication date: May 27, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael John Millan
  • Tartrate salts of thiazolidinedione derivative
    Publication number: 20040087629
    Abstract: A novel pharmaceutical compound 5-[4-2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione L(+) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 16, 2003
    Publication date: May 6, 2004
    Inventors: Berndette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • 5'-4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
    Publication number: 20040082620
    Abstract: Disclosed are 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salts, or solvates thereof; processes for preparing such compounds, compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: December 4, 2003
    Publication date: April 29, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael Millan, Deirdre O'Keeffe
  • Tartrate salts of thiazollidnedione derivative
    Publication number: 20040048899
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione D(−) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: July 30, 2003
    Publication date: March 11, 2004
    Inventors: Bernadette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • Thiazolidinedione derivative and its use as antidiabetic
    Publication number: 20040044043
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione ethanesulfonate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 4, 2004
    Inventors: Andrew Simon Craig, Michael John Millan
  • Paroxetine compositions
    Patent number: 6699882
    Abstract: Paroxetine is adsorbed on a carrier to form a free-flowing powder useful for capsule filling or for tablet formulation; and used in therapy to treat depression.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: March 2, 2004
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Andrew Simon Craig, Neal Ward
  • Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dione
    Publication number: 20040034066
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: July 16, 2003
    Publication date: February 19, 2004
    Inventors: Andrew Simon Craig, Michael Millan
  • Thiazolidinone nitrate salt
    Publication number: 20040029926
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione nitrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: June 17, 2003
    Publication date: February 12, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Deirdre O'Keeffe
  • 5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
    Publication number: 20040024027
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydriodide or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: June 10, 2003
    Publication date: February 5, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael John Millan
  • Sodium salts of 5-[4-]2-(n-methyl-N-(2-pyridyl) ethoxy]benzyl]thiazolidine-2,4-dione
    Publication number: 20040014752
    Abstract: A compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione sodium salt, or a pharmaceutically acceptable solvate thereof, characterised in that the sodium salt is non-hygroscopic or slightly hygroscapic; a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 22, 2004
    Inventors: Andrew Simon Craig, Michael Millan
  • Thiazolidinedione derivative and its use as antidiabetic
    Publication number: 20040014791
    Abstract: A novel pharmaceutical compound 5-[4-[2-methyl-N-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dione fumarate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: June 17, 2003
    Publication date: January 22, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho
  • Tartrate salt of thiazolidinedione derivative
    Publication number: 20040014790
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione DL-Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: June 17, 2003
    Publication date: January 22, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho